Evaluating the Long-Term Efficacy of COVID-19 Vaccines

Dan-Yu Lin, Donglin Zeng, Peter B. Gilbert
doi: https://doi.org/10.1101/2021.01.13.21249779

Article Information

doi 
https://doi.org/10.1101/2021.01.13.21249779
History 
  • March 9, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Dan-Yu Lin1,*,
  2. Donglin Zeng1 and
  3. Peter B. Gilbert2
  1. 1Department of Biostatistics, University of North Carolina, Chapel Hill, North Carolina, USA
  2. 2Vaccine and Infectious Disease Division, Fred Hutch, Seattle, Washington, USA
  1. ↵*Correspondence: Dan-Yu Lin, PhD, Department of Biostatistics, University of North Carolina, Chapel Hill, NC 27599-7420, USA (lin{at}bios.unc.edu).
Back to top
Posted March 09, 2021.
Download PDF
Data/Code
Email
Evaluating the Long-Term Efficacy of COVID-19 Vaccines
Dan-Yu Lin, Donglin Zeng, Peter B. Gilbert
medRxiv 2021.01.13.21249779; doi: https://doi.org/10.1101/2021.01.13.21249779
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area